Classification ![]() |
|
Compound class | Peptide or derivative |
Approved drug? | Yes (EMA & FDA (2014)) |
International Nonproprietary Names ![]() |
|
INN number | INN |
9686 | elosulfase alfa |
Synonyms ![]() |
BMN 110 | rhGALNS | Vimizim® |
Comments |
Elosulfase alfa is a recombinant enzyme replacement therapy for galactosamine (N-acetyl)-6-sulfatase (GALNS, P34059) deficiency. The peptide is translated from the human cDNA expressed in CHO cells [1]. |
Database Links ![]() |
|
CAS Registry No. | 9025-60-9 (source: SciFinder) |
GtoPdb PubChem SID | 178103964 |
Search PubMed clinical trials | elosulfase alfa |
Search PubMed titles | elosulfase alfa |
Search PubMed titles/abstracts | elosulfase alfa |
Wikipedia | Elosulfase_alfa |